Return to the Cognitive Enhancement Research Institute
Home Page.
Read information about Smart Drug News
and book reprint copyrights and permissions.
Table of Contents:
All About This Web Site
— What CERI information is and is not posted on this site
— Information bias of this site, what if you don’t understand something
How to Navigate This Site
— How/where to click, underlined/highlighted items, golden diamonds & yellow balls
Readability and Text Size
— Changing the size of fonts
The Purpose of This Site
— Attracting prospective subscribers & information of vital social importance
Downloading Speed and Graphics
— How much time it takes to download files, and graphics graininess
File Organization
— Files, hubs, menus, sidebars
Tables of Contents
— jumpimg into and out of files
Doing Business with CERI.
All About This Web Site
What you see here at this web site is ten years of careful research and
suscinct writing. This contains 180 web pages linked
through 12 primary menus, and all 72 complete newsletters as searchable PDF
files stored in the cloud for your reading, downloading and printing pleasure.
To access this information, use the menus or use the newsletter back issues menu and scroll through the paragraphs describing each newsletter’s
contents, the highlighted (and/or underlined) items are posted as web files
on this site. The non-highlighted (regular, ordinary text) items are only
posted as PDF files of the entire issue. The links to those PDF files are
in the header above the paragraph. When you click on those links, the PDF
file will load from the Google cloud into your PDF viewing program.
You can then search for the article or question and answer you were interested
in, or save it to your computer and print it out on your printer.
What you see here at CERI’s web site might lead you to believe
that CERI is very “disease oriented,” or pharmaceutical-oriented or
GHB oriented. It is true that a lot of the files on this site are about
Down’s syndrome, Parkinson’s disease and gamma-hydroxybutyrate.
This is because almost every thing we have published on those subjects is
posted here on this site. So you might want to judge those topics as
examples of our thoroughness, not our focus. Our primary effort is
directed towards normal, healthy humans who are trying to optimize their
performance and age gracefully in a less than ideal world. We talk about
nutrients much more frequently than drugs. This “general” material
is just not proportionately represented on this web site.
There are two reasons for this:
First, we survived by selling this information. We did not have wealthy
patrons underwriting our institute. We were supported by our subscribers.
We wanted you to subscribe to our newsletter so that we could continue to
do our work. Although this is no longer true regarding publishing, we still
appreciate the value of not having financial conflicts of interest in relating
information, even though our outreach is now in blog-space.
Second, this “general” information is not of critical
“social” importance. That’s not to say that it isn’t
invaluable or important. It is very valuable and important.
It is valuable to individuals, not society. It is important to people
who are productive and involved, who are interested in learning, with
a passion about making something of themselves. It is quality
information produced by people who care about these same things.
And it is a cut above what you are likely to find elsewhere.
Maybe this information is for you. All we can say is read on, and judge
for yourself if you think this is your “cup of tea.” There is a wide
variety of information from which to choose. Explore, and have fun!
Some visitors may find our information extremely challenging.
It is. So do not feel bad if you don’t understand something. Remember,
these articles were written for people who have been previously introduced
to cognitive enhancement and longevity. They have read introductory books.
If you have not read this "background" material, you may feel like you've
jumped into the deep end of the pool.
Don’t despair.
You can read back issues.
You can read introductory books.
You can ask questions about anything you do not understand.
The primary question is not whether or not you understand everything,
but whether or not you want to know more.
Do you learn something when you read our material?
Does it give you insight into your life?
Does it relate to people you care about?
Do questions pop into your head as you are reading?
Do you have any “Aha!” experiences?
Are you left with a sense of accomplishment?
You can find out something about the kind of people who subscribed
to Smart Life News by reading what our
subscribers have to say about us.
How to Navigate this Site
Navigating this web site is relatively simple. Pages on this site are
“linked” to each other by 1) small golden diamonds next to the selection,
or 2) highlighted or underlined words or phrases. All you have to do
is click the cursor of your web browser program on a golden diamond or
highlighted/underlined phrase and you will be taken to the appropriate file.
Clicking on the “back” button on your web browser program will reverse
the process, bringing you back to where you were. There is also a
return-to-the-CERI-home-page option on most pages that will take you all the way
back to the home page in a single click. That’s the essential information
you need to navigate through this web site.
One word of caution: clicking on the yellow spheres seen throughout this web
site will not link you to that selection. The yellow spheres are used only to
visually highlight items of information. The diamonds are linked, the spheres
are not.
Readability (Text Size)
Can you read this?
Can you read this?
Can you read this?
Can you read this?
Can you read this?
Most web-browser programs have an option for changing the size of the
letters on the computer screen. If you are having problems reading this
because of the small size of the letters on your screen, use the font
option to select a bigger font. This may cause some “wrapping”
to occur on some of the menu pages when the line length exceeds the
width of your screen. Although this may detract from the appearance of
this site, it will not impair its function. These font-change options
will not affect the size of graphics. If you want
access to higher resolution images, for example, for PowerPoint presentations
or for transparencies, please call.
The Purpose of this Site
This web site is intended for two purposes:
1) to familiarize prospective subscribers with the work that we do
through examples of the work that we have done, and
2) to spread information that we feel is of vital social importance.
This latter purpose includes:
1) a new smart-drug-and-nutrient treatment for
Down’s syndrome,
2) Alzheimer’s disease treatment options;
including the chapter from
Smart Drugs II and the Smart Life News
feature article.
3) an antioxidant-plus-deprenyl therapy for
Parkinson’s disease;
4) editorial critiques of social policies towards
smart drugs,
5) the FDA’s irrational policy towards the essential amino
acid L-tryptophan,
6) anticompetitiveness among
deprenyl manufacturers, and
7) the govermental criminalization of
the nutritional substance GHB; and
8) personal “lifestyle” information about how to deal with
holiday stress, and
9) how to use nutrients to minimize the toxicity of
alcohol (i.e., prevent
hangovers,
neurotoxicity and liver damage) while maximizing the benefits of alcohol and red wine.
We have attempted to put something on this site for everybody.
However, we wish to remind all visitors that this site contains
only a small fraction of the total literature that we have available.
Please do not assume that we do not have information and/or resources
that you do not find on this site.
This web site currently contains more than 5 megabytes of files.
This is made up of more than 150 text (web) files (more than a megabyte
and a half total size) and more than 120 graphics files (approximately
4 megabytes total size). Because it used to take a long time to load a megabyte,
there may be significant waits if you have an old computer when you access large
files or files with large graphics (like the detailed
mitochondrial graphic in the article
on “Mitochondrial Nutrition, Aging and Cognition” or Steve Fowkes’
steroid-tree graphic in the question-and-answer on
androstenedione vs androstenediol). We have
made a significant effort to minimize the sizes of the graphics files
to maximize speed of loading, however, there is always a compromise
between speed and legibility (i.e., detail). We have reduced
these file sizes to the point that some of the fine detail is pretty
grainy, but not far enough that it is illegible.
This “graininess” is an artifact of the digitization process
that converts the graphics into a computer-displayable form. About 90%
of the resolution of the original images is lost when they are converted
to fit your video screen. In other words, the original graphic images
in the newsletter articles are about ten times more crisp and clear
than what you see on the screen.
The CERI Home Page (index.htm)
is the hub for this site. Like spokes on a wheel, this home page
is directly or indirectly linked to all of the menus and files on this site.
In many cases, the Home Page is linked to a satelite page
which serves as a hub to a smaller collection of related files.
For example, the Home Page is connected to the
Down’s Syndrome Page, which serves as
a gateway to all the files dealing with the subject of Down’s
syndrome. The Down’s Page has five links to major articles and
five links to sidebars. The sidebars are also linked within each
of the articles. While this may seem complicated (it is), it is
also simple: links are placed at multiple spots that makes it convenient
to the browser (you) to reference related information. For example,
the sidebar on free radicals is linked
to each use of the term in the Antioxidant
Intervention in Down’s Syndrome article.
The first time you use a link, the highlight or underlining
will change to indicate that you have already been to that link.
By paying attention to the color of the link, you can avoid clicking on
links to files you’ve already read. If you do access a file that
you’ve already read, the “back” option will quickly return you
to the previous file at the place you left it.
Some of the larger files have a table of contents (an index) that
will allow you to “jump” to preselected locations within
those files. The newsletter back-issue descriptions are organized into
volumes (ten issues per file), with a table of contents at the beginning
that allows you to jump to any specific back issue. Again, the “back“
button reverses the process by returning you to the index.
We appreciate your interest and support.
